CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
NorDx, a large reference laboratory in Maine that is a member of MaineHealth, has acquired Sysmex America’s XN-3000 automated hematology analyzers. The XN-3000 configuration enables enhanced diagnostic capabilities and greater efficiency that transforms NorDx into an accountable care laboratory model.
The Sysmex XN-3000 has a menu of advanced clinical parameters that allows NorDx and MaineHealth to conduct cellular studies that enable the quantitative assessments of red cell, white cell, and platelet precursors, guiding diagnosis and treatment by the physician. These parameters include NRBCs with every CBC, immature granulocytes with every differential, RET-He within the reticulocyte profile, and a fluorescent platelet channel for IPF to aid the physician in the differential diagnosis of thrombocytopenia.
NorDx and MaineHealth invested in the Sysmex XN-3000s to help address cost and labor pressures, including the projected shortage of medical technologists, increasing workload demands, and the testing complexity of an aging population. The analyzer’s small footprint optimizes workflow efficiency, staffing, and space. Smaller reagent sizes and concentrated reagents simplify consumable inventory management.
Sysmex America, 800-462-1262 NorDx, 207-396-7830